MARK A GOLDSMITH, the See Remarks of $RVMD, sold 30,000 shares of the company on 11-07-2025 for an estimated $1,809,306. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.9% of their shares of this class of stock. Following this trade, they now own 347,863 shares of this class of $RVMD stock.
$RVMD Insider Trading Activity
$RVMD insiders have traded $RVMD stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $RVMD stock by insiders over the last 6 months:
- STEPHEN MICHAEL KELSEY (See Remarks) has made 0 purchases and 7 sales selling 159,656 shares for an estimated $7,188,067.
- MARK A GOLDSMITH (See Remarks) has made 0 purchases and 5 sales selling 76,907 shares for an estimated $4,016,110.
- JEFF CISLINI (General Counsel) has made 0 purchases and 5 sales selling 19,458 shares for an estimated $975,807.
- JACK ANDERS (Chief Financial Officer) has made 0 purchases and 4 sales selling 14,490 shares for an estimated $593,737.
- MARGARET A HORN (Chief Operating Officer) has made 0 purchases and 2 sales selling 8,285 shares for an estimated $358,617.
- LIN WEI (Chief Medical Officer) has made 0 purchases and 2 sales selling 4,333 shares for an estimated $185,532.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RVMD Hedge Fund Activity
We have seen 176 institutional investors add shares of $RVMD stock to their portfolio, and 131 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,015,869 shares (+180.2%) to their portfolio in Q2 2025, for an estimated $110,953,820
- DEERFIELD MANAGEMENT COMPANY, L.P. added 2,492,485 shares (+279.6%) to their portfolio in Q2 2025, for an estimated $91,698,523
- WELLINGTON MANAGEMENT GROUP LLP removed 1,528,183 shares (-13.0%) from their portfolio in Q2 2025, for an estimated $56,221,852
- BAKER BROS. ADVISORS LP added 1,428,000 shares (+18.0%) to their portfolio in Q2 2025, for an estimated $52,536,120
- CITADEL ADVISORS LLC added 1,344,608 shares (+1010.5%) to their portfolio in Q2 2025, for an estimated $49,468,128
- MILLENNIUM MANAGEMENT LLC added 1,224,488 shares (+783.2%) to their portfolio in Q2 2025, for an estimated $45,048,913
- VESTAL POINT CAPITAL, LP added 1,200,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $44,148,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RVMD Analyst Ratings
Wall Street analysts have issued reports on $RVMD in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wedbush issued a "Outperform" rating on 11/06/2025
- Needham issued a "Buy" rating on 11/06/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/06/2025
- JP Morgan issued a "Overweight" rating on 11/06/2025
- RBC Capital issued a "Outperform" rating on 11/03/2025
- Mizuho issued a "Outperform" rating on 10/21/2025
- Raymond James issued a "Strong Buy" rating on 10/17/2025
To track analyst ratings and price targets for $RVMD, check out Quiver Quantitative's $RVMD forecast page.
$RVMD Price Targets
Multiple analysts have issued price targets for $RVMD recently. We have seen 15 analysts offer price targets for $RVMD in the last 6 months, with a median target of $77.0.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $73.0 on 11/06/2025
- Ami Fadia from Needham set a target price of $72.0 on 11/06/2025
- Robert Driscoll from Wedbush set a target price of $80.0 on 11/06/2025
- Brian Cheng from JP Morgan set a target price of $82.0 on 11/06/2025
- Leonid Timashev from RBC Capital set a target price of $77.0 on 11/03/2025
- Joseph Catanzaro from Mizuho set a target price of $90.0 on 10/21/2025
- Sean McCutcheon from Raymond James set a target price of $76.0 on 10/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
